News articles about Surgery Partners (NASDAQ:SGRY) have trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Surgery Partners earned a news impact score of 0.10 on Accern’s scale. Accern also gave news stories about the company an impact score of 46.6323678345291 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Shares of Surgery Partners (SGRY) traded down 2.67% during mid-day trading on Thursday, reaching $9.10. 548,742 shares of the company traded hands. Surgery Partners has a 52-week low of $8.52 and a 52-week high of $24.05. The stock’s 50 day moving average is $9.88 and its 200 day moving average is $17.11. The stock has a market capitalization of $444.18 million, a PE ratio of 59.87 and a beta of 2.05.
Several research analysts have recently commented on the stock. Stifel Nicolaus lowered shares of Surgery Partners from a “hold” rating to a “sell” rating and decreased their price target for the company from $21.00 to $17.00 in a report on Wednesday, August 9th. Zacks Investment Research lowered shares of Surgery Partners from a “hold” rating to a “strong sell” rating in a report on Saturday, August 12th. Citigroup Inc. reaffirmed a “buy” rating and issued a $17.00 price target (down from $28.00) on shares of Surgery Partners in a report on Friday, August 11th. Raymond James Financial, Inc. reiterated a “market perform” rating on shares of Surgery Partners in a research report on Wednesday, August 9th. Finally, Bank of America Corporation cut their price objective on shares of Surgery Partners from $23.00 to $19.00 and set a “buy” rating on the stock in a research report on Monday. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company. Surgery Partners has a consensus rating of “Hold” and a consensus target price of $19.29.
In other news, major shareholder H.I.G. Surgery Centers, Llc sold 26,455,651 shares of the company’s stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $19.00, for a total value of $502,657,369.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 7.50% of the stock is currently owned by corporate insiders.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.